A Tale of Two Pathways: Renewing the Promise of Anti-CD40L Blockade
- PMID: 28141921
- DOI: 10.1111/ajt.14217
A Tale of Two Pathways: Renewing the Promise of Anti-CD40L Blockade
Keywords: animal models: nonhuman primate; costimulation; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: costimulation molecule specific; immunosuppressant; immunosuppression/immune modulation; kidney transplantation/nephrology; translational research/science.
Comment on
-
Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.Am J Transplant. 2017 May;17(5):1182-1192. doi: 10.1111/ajt.14197. Epub 2017 Feb 25. Am J Transplant. 2017. PMID: 28097811 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
